![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessCRISPR-based kinome-screening revealed MINK1 as a druggable player to rewire 5FU-resistance in OSCC through AKT/MDM2/p53 axis
Cisplatin, 5FU and docetaxel (TPF) are the most common chemotherapy regimen used for advanced OSCC. However, many cancer patients experience relapse, continued tumor growth, and spread due to drug resistance, ...
-
Chapter
Epidemic Incidence Modeling and Forecasting Geospatially Using Machine Learning
Due to climate changes and other socio-economic and anthropogenic in the world there is surgency in the epidemics and pandemics. Malaria is one of the oldest pandemics and still causing numerous deaths. Normal...
-
Article
Correction: RRBP1 rewires cisplatin resistance in oral squamous cell carcinoma by regulating Hippo pathway
-
Article
RRBP1 rewires cisplatin resistance in oral squamous cell carcinoma by regulating Hippo pathway
Chemoresistance is one of the major factors for treatment failure in OSCC. Identifying key resistance triggering molecules will be useful strategy for develo** novel treatment methods.